Anbio Biotechnology: cost_of_revenue
| Value | {"amount": 1103682, "concept": "us-gaap:CostOfRevenue", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/121cfe1c-ce1d-4a1a-ac5f-0948adb98747
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001185185-26-001294Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001982708/cost-of-revenue/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/121cfe1c-ce1d-4a1a-ac5f-0948adb98747
History
- no predecessors — first report